CA Stock MarketDetailed Quotes

Optimind Pharma Corp (OMND)

Watchlist
  • 0.005
  • 0.0000.00%
15min DelayMarket Closed Aug 19 13:59 ET
515.74KMarket Cap-5.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Optimind Pharma Corp (OMND) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Nov 30, 2025
(Q2)Aug 31, 2025
(Q1)May 31, 2025
(FY)Feb 28, 2025
(Q4)Feb 28, 2025
(Q3)Nov 30, 2024
(Q2)Aug 31, 2024
(Q1)May 31, 2024
(FY)Feb 29, 2024
(Q4)Feb 29, 2024
Total revenue
28.12%34.03K
-34.12%27.05K
122.47%35.71K
-3.73%118.37K
25.45%34.7K
-0.43%26.56K
50.12%41.06K
-61.12%16.05K
-27.72%122.96K
-35.17%27.66K
Operating revenue
28.12%34.03K
-34.12%27.05K
122.47%35.71K
-3.73%118.37K
25.45%34.7K
-0.43%26.56K
50.12%41.06K
-61.12%16.05K
-27.72%122.96K
-35.17%27.66K
Cost of revenue
Gross profit
Operating expense
75.97%62.65K
-69.35%37.89K
-68.30%36K
-62.44%334.18K
-62.99%61.4K
-70.87%35.6K
-32.77%123.63K
-72.83%113.55K
-34.85%889.83K
-11.78%165.9K
Selling and administrative expenses
46.47%32.19K
-79.47%21.54K
-76.99%22.76K
-59.84%268.66K
-73.10%42.89K
-78.44%21.98K
-28.83%104.89K
-61.99%98.91K
-26.62%668.98K
21.46%159.46K
-General and administrative expense
46.47%32.19K
-79.47%21.54K
-76.99%22.76K
-59.84%268.66K
-73.10%42.89K
-78.44%21.98K
-28.83%104.89K
-61.99%98.91K
-26.62%668.98K
21.46%159.46K
Research and development costs
----
----
----
--0
--0
--0
--0
--0
--120K
--0
Depreciation amortization depletion
----
----
----
--0
--0
--0
--0
--0
-54.39%19.95K
--0
-Depreciation and amortization
----
----
----
--0
--0
--0
--0
--0
-54.39%19.95K
--0
Other operating expenses
123.56%30.45K
-12.75%16.35K
-9.57%13.24K
-19.01%65.52K
187.39%18.51K
-10.65%13.62K
-35.44%18.74K
-51.48%14.64K
-80.29%80.89K
-85.95%6.44K
Operating profit
-216.49%-28.62K
86.88%-10.84K
99.70%-294
71.86%-215.81K
80.68%-26.7K
90.53%-9.04K
47.25%-82.56K
74.11%-97.5K
35.86%-766.87K
4.92%-138.24K
Net non-operating interest income (expenses)
0
0
0
0
0
-22.81%-91.3K
55.70%-11.92K
Non-operating interest expense
----
----
----
--0
--0
--0
--0
--0
22.81%91.3K
-55.70%11.92K
Other net income (expenses)
69.83%-548.17K
-564.61K
Special income (charges)
----
----
----
--0
--0
--0
----
----
69.83%-548.17K
68.93%-564.61K
-Less:Impairment of capital assets
----
----
----
--0
--0
--0
----
----
-75.37%371.25K
-74.28%387.69K
-Less:Other special charges
----
----
----
----
----
----
----
----
---16.44K
----
-Less:Write off
----
----
----
--0
----
----
----
----
-37.63%193.36K
----
Income before tax
-216.49%-28.62K
86.88%-10.84K
99.70%-294
84.65%-215.81K
96.26%-26.7K
91.34%-9.04K
55.01%-82.56K
75.85%-97.5K
54.45%-1.41M
64.07%-714.77K
Income tax
0
0
0
0
0
0
0
0
1.02%-8.76K
-52.22%-8.76K
Earnings from equity interest net of tax
Net income
-216.49%-28.62K
86.88%-10.84K
99.70%-294
84.56%-215.81K
96.22%-26.7K
91.34%-9.04K
55.01%-82.56K
75.85%-97.5K
54.60%-1.4M
64.41%-706.01K
Net income continuous operations
-216.49%-28.62K
86.88%-10.84K
99.70%-294
84.56%-215.81K
96.22%-26.7K
91.34%-9.04K
55.01%-82.56K
75.85%-97.5K
54.60%-1.4M
64.41%-706.01K
Noncontrolling interests
Net income attributable to the company
-216.49%-28.62K
86.88%-10.84K
99.70%-294
84.56%-215.81K
96.22%-26.7K
91.34%-9.04K
55.01%-82.56K
75.85%-97.5K
54.60%-1.4M
64.41%-706.01K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-216.49%-28.62K
86.88%-10.84K
99.70%-294
84.56%-215.81K
96.22%-26.7K
91.34%-9.04K
55.01%-82.56K
75.85%-97.5K
54.60%-1.4M
64.41%-706.01K
Diluted earnings per share
-200.00%-0.0003
0
0
85.71%-0.002
95.65%-0.0003
90.91%-0.0001
50.00%-0.001
75.00%-0.001
65.00%-0.014
73.46%-0.0069
Basic earnings per share
-200.00%-0.0003
0
0
85.71%-0.002
95.65%-0.0003
90.91%-0.0001
50.00%-0.001
75.00%-0.001
65.00%-0.014
73.46%-0.0069
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Nov 30, 2025(Q2)Aug 31, 2025(Q1)May 31, 2025(FY)Feb 28, 2025(Q4)Feb 28, 2025(Q3)Nov 30, 2024(Q2)Aug 31, 2024(Q1)May 31, 2024(FY)Feb 29, 2024(Q4)Feb 29, 2024
Total revenue 28.12%34.03K-34.12%27.05K122.47%35.71K-3.73%118.37K25.45%34.7K-0.43%26.56K50.12%41.06K-61.12%16.05K-27.72%122.96K-35.17%27.66K
Operating revenue 28.12%34.03K-34.12%27.05K122.47%35.71K-3.73%118.37K25.45%34.7K-0.43%26.56K50.12%41.06K-61.12%16.05K-27.72%122.96K-35.17%27.66K
Cost of revenue
Gross profit
Operating expense 75.97%62.65K-69.35%37.89K-68.30%36K-62.44%334.18K-62.99%61.4K-70.87%35.6K-32.77%123.63K-72.83%113.55K-34.85%889.83K-11.78%165.9K
Selling and administrative expenses 46.47%32.19K-79.47%21.54K-76.99%22.76K-59.84%268.66K-73.10%42.89K-78.44%21.98K-28.83%104.89K-61.99%98.91K-26.62%668.98K21.46%159.46K
-General and administrative expense 46.47%32.19K-79.47%21.54K-76.99%22.76K-59.84%268.66K-73.10%42.89K-78.44%21.98K-28.83%104.89K-61.99%98.91K-26.62%668.98K21.46%159.46K
Research and development costs --------------0--0--0--0--0--120K--0
Depreciation amortization depletion --------------0--0--0--0--0-54.39%19.95K--0
-Depreciation and amortization --------------0--0--0--0--0-54.39%19.95K--0
Other operating expenses 123.56%30.45K-12.75%16.35K-9.57%13.24K-19.01%65.52K187.39%18.51K-10.65%13.62K-35.44%18.74K-51.48%14.64K-80.29%80.89K-85.95%6.44K
Operating profit -216.49%-28.62K86.88%-10.84K99.70%-29471.86%-215.81K80.68%-26.7K90.53%-9.04K47.25%-82.56K74.11%-97.5K35.86%-766.87K4.92%-138.24K
Net non-operating interest income (expenses) 00000-22.81%-91.3K55.70%-11.92K
Non-operating interest expense --------------0--0--0--0--022.81%91.3K-55.70%11.92K
Other net income (expenses) 69.83%-548.17K-564.61K
Special income (charges) --------------0--0--0--------69.83%-548.17K68.93%-564.61K
-Less:Impairment of capital assets --------------0--0--0---------75.37%371.25K-74.28%387.69K
-Less:Other special charges -----------------------------------16.44K----
-Less:Write off --------------0-----------------37.63%193.36K----
Income before tax -216.49%-28.62K86.88%-10.84K99.70%-29484.65%-215.81K96.26%-26.7K91.34%-9.04K55.01%-82.56K75.85%-97.5K54.45%-1.41M64.07%-714.77K
Income tax 000000001.02%-8.76K-52.22%-8.76K
Earnings from equity interest net of tax
Net income -216.49%-28.62K86.88%-10.84K99.70%-29484.56%-215.81K96.22%-26.7K91.34%-9.04K55.01%-82.56K75.85%-97.5K54.60%-1.4M64.41%-706.01K
Net income continuous operations -216.49%-28.62K86.88%-10.84K99.70%-29484.56%-215.81K96.22%-26.7K91.34%-9.04K55.01%-82.56K75.85%-97.5K54.60%-1.4M64.41%-706.01K
Noncontrolling interests
Net income attributable to the company -216.49%-28.62K86.88%-10.84K99.70%-29484.56%-215.81K96.22%-26.7K91.34%-9.04K55.01%-82.56K75.85%-97.5K54.60%-1.4M64.41%-706.01K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -216.49%-28.62K86.88%-10.84K99.70%-29484.56%-215.81K96.22%-26.7K91.34%-9.04K55.01%-82.56K75.85%-97.5K54.60%-1.4M64.41%-706.01K
Diluted earnings per share -200.00%-0.00030085.71%-0.00295.65%-0.000390.91%-0.000150.00%-0.00175.00%-0.00165.00%-0.01473.46%-0.0069
Basic earnings per share -200.00%-0.00030085.71%-0.00295.65%-0.000390.91%-0.000150.00%-0.00175.00%-0.00165.00%-0.01473.46%-0.0069
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -